A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington’s disease mice
Núria Suelves(Biomedical Research Networking Center on Neurodegenerative Diseases), Sílvia Ginés(Biomedical Research Networking Center on Neurodegenerative Diseases)
Cited by 76
Related Papers
Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity
|Human Molecular Genetics|2011|149
Imbalance of p75NTR/TrkB protein expression in Huntington’s disease: implication for neuroprotective therapies
|Cell Death and Disease|2013|89
Impaired TrkB-mediated ERK1/2 Activation in Huntington Disease Knock-in Striatal Cells Involves Reduced p52/p46 Shc Expression
|Journal of Biological Chemistry|2010|72
A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's disease
|Human Molecular Genetics|2015|53